ExodusPoint Capital Management’s Dermira, Inc. DERM Stock Holding History

ExodusPoint Capital Management’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-37,733	Closed	-$241K	–	2058
2019 Q3	$241K	Buy	37,733 +21,831	+137%	+$182K	0.01%	1021
2019 Q2	$152K	Buy	+15,902	New	+$171K	0.01%	976
2019 Q1	–	Sell	-46,811	Closed	-$337K	–	804
2018 Q4	$337K	Buy	+46,811	New	+$512K	0.02%	183

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ExodusPoint Capital Management's DERM Position: Q4 2019 in Review

ExodusPoint Capital Management sold out of Dermira, Inc. (DERM) in Q4 2019, closing a stake of 37,733 shares — an estimated $241K sold.

ExodusPoint Capital Management first reported a position in DERM in Q4 2018 and held it in 3 quarters. The position peaked at $337K in Q4 2018. 133 funds tracked by Wall St. Rank hold DERM as of Q4 2019.

ExodusPoint Capital Management reported no remaining Dermira, Inc. position as of Q4 2019 after selling out during the quarter.
ExodusPoint Capital Management sold 37,733 Dermira, Inc. shares in Q4 2019, an estimated $241K.
ExodusPoint Capital Management first reported a position in Dermira, Inc. in Q4 2018 and held it in 3 quarters.
ExodusPoint Capital Management's Dermira, Inc. position peaked at $337K in Q4 2018.
133 funds tracked by Wall St. Rank held Dermira, Inc. as of Q4 2019.

Based on ExodusPoint Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.